| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| L Isaac, R Mills, L J Fowler, B S Starr, M S Star. Putative neurotoxicity of SKF 38393 and other D1 dopaminergic drugs investigated in rat striatum. Journal of neurochemistry. vol 58. issue 4. 1992-04-17. PMID:1347781. |
putative neurotoxicity of skf 38393 and other d1 dopaminergic drugs investigated in rat striatum. |
1992-04-17 |
2023-08-11 |
rat |
| L Isaac, R Mills, L J Fowler, B S Starr, M S Star. Putative neurotoxicity of SKF 38393 and other D1 dopaminergic drugs investigated in rat striatum. Journal of neurochemistry. vol 58. issue 4. 1992-04-17. PMID:1347781. |
it is concluded that none of the d1 dopaminergic compounds examined here was neurotoxic toward the many different cell groups that contain ache and/or gad in the striatum. |
1992-04-17 |
2023-08-11 |
rat |
| Y Akiyama, A Ito, K Koshimura, T Ohue, S Yamagata, S Miwa, H Kikuch. Effects of transient forebrain ischemia and reperfusion on function of dopaminergic neurons and dopamine reuptake in vivo in rat striatum. Brain research. vol 561. issue 1. 1992-04-16. PMID:1797339. |
effects of transient forebrain ischemia and reperfusion on function of dopaminergic neurons and dopamine reuptake in vivo in rat striatum. |
1992-04-16 |
2023-08-11 |
rat |
| Y Akiyama, A Ito, K Koshimura, T Ohue, S Yamagata, S Miwa, H Kikuch. Effects of transient forebrain ischemia and reperfusion on function of dopaminergic neurons and dopamine reuptake in vivo in rat striatum. Brain research. vol 561. issue 1. 1992-04-16. PMID:1797339. |
to clarify functional changes of dopaminergic neurons and dopamine (da) reuptake during and after ischemia, extracellular da levels in striatum were determined using in vivo brain microdialysis in a 4-vessel occlusion model of male wistar rats with and without pharmacological interventions. |
1992-04-16 |
2023-08-11 |
rat |
| X Z Ding, I Mocchett. Dopaminergic regulation of cholecystokinin mRNA content in rat striatum. Brain research. Molecular brain research. vol 12. issue 1-3. 1992-04-13. PMID:1312208. |
dopaminergic regulation of cholecystokinin mrna content in rat striatum. |
1992-04-13 |
2023-08-11 |
rat |
| X Z Ding, I Mocchett. Dopaminergic regulation of cholecystokinin mRNA content in rat striatum. Brain research. Molecular brain research. vol 12. issue 1-3. 1992-04-13. PMID:1312208. |
the nigrostriatal dopaminergic activity was pharmacologically changed to assess whether dopamine (da) regulates cholecystokinin (cck) mrna steady state in rat striatum. |
1992-04-13 |
2023-08-11 |
rat |
| X Z Ding, I Mocchett. Dopaminergic regulation of cholecystokinin mRNA content in rat striatum. Brain research. Molecular brain research. vol 12. issue 1-3. 1992-04-13. PMID:1312208. |
cocaine and benztropine, two dopaminergic agonists known to induce da release and to block its re-uptake, produced a time dependent increase in cck mrna content in rat striatum. |
1992-04-13 |
2023-08-11 |
rat |
| X Z Ding, I Mocchett. Dopaminergic regulation of cholecystokinin mRNA content in rat striatum. Brain research. Molecular brain research. vol 12. issue 1-3. 1992-04-13. PMID:1312208. |
haloperidol, a dopaminergic receptor blocker, injected at 1 mg/kg, i.p., daily for 7 days, decreased cck mrna content in striatum but not in the cerebral cortex. |
1992-04-13 |
2023-08-11 |
rat |
| M Savasta, F Mennicken, M Chritin, D N Abrous, C Feuerstein, M Le Moal, J P Herma. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study. Neuroscience. vol 46. issue 3. 1992-04-13. PMID:1532053. |
one month later animals were killed and striatal dopaminergic receptor densities were quantified using autoradiography, the dopaminergic reinnervation of the host striatum being visualized with [3h]gbr 12935, a ligand labelling dopamine uptake sites. |
1992-04-13 |
2023-08-11 |
rat |
| M Savasta, F Mennicken, M Chritin, D N Abrous, C Feuerstein, M Le Moal, J P Herma. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study. Neuroscience. vol 46. issue 3. 1992-04-13. PMID:1532053. |
the normal distribution of d1 and d2 dopaminergic receptors in the rat striatum was similar to that described previously. |
1992-04-13 |
2023-08-11 |
rat |
| M Savasta, F Mennicken, M Chritin, D N Abrous, C Feuerstein, M Le Moal, J P Herma. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study. Neuroscience. vol 46. issue 3. 1992-04-13. PMID:1532053. |
the implantation of embryonic dopaminergic neurons into the denervated striatum led to a slight decrease of d1 receptor densities and to a reversal of the lesion-induced increase of striatal dopaminergic d2 receptors six months later. |
1992-04-13 |
2023-08-11 |
rat |
| M A Cenci, P Kalén, R J Mandel, K Wictorin, A Björklun. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum. Neuroscience. vol 46. issue 4. 1992-04-09. PMID:1347413. |
dopaminergic transplants normalize amphetamine- and apomorphine-induced fos expression in the 6-hydroxydopamine-lesioned striatum. |
1992-04-09 |
2023-08-11 |
rat |
| M A Cenci, P Kalén, R J Mandel, K Wictorin, A Björklun. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum. Neuroscience. vol 46. issue 4. 1992-04-09. PMID:1347413. |
dopamine receptor-mediated fos protein expression in the striatum has been used to monitor dopamine receptor activation at the cellular level after dopaminergic denervation and reinnervation by fetal nigral transplants. |
1992-04-09 |
2023-08-11 |
rat |
| M A Cenci, P Kalén, R J Mandel, K Wictorin, A Björklun. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum. Neuroscience. vol 46. issue 4. 1992-04-09. PMID:1347413. |
the pattern of striatal fos expression after systemic administration of either the dopamine receptor agonist, apomorphine, or the dopamine-releasing agent, amphetamine, was studied in rats which had received cell suspension grafts of fetal ventral mesencephalic neurons into the striatum after a complete 6-hydroxydopamine lesion of mesostriatal dopaminergic projection. |
1992-04-09 |
2023-08-11 |
rat |
| G S Robertson, H C Fibige. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience. vol 46. issue 2. 1992-04-08. PMID:1347406. |
destruction of mesotelencephalic dopaminergic neurons with 6-hydroxydopamine abolished the increase in fos expression in the nucleus accumbens and striatum produced by haloperidol and raclopride, and also blocked the clozapine-induced increase in the nucleus accumbens. |
1992-04-08 |
2023-08-11 |
Not clear |
| J W Polli, M L Billingsley, R L Kincai. Expression of the calmodulin-dependent protein phosphatase, calcineurin, in rat brain: developmental patterns and the role of nigrostriatal innervation. Brain research. Developmental brain research. vol 63. issue 1-2. 1992-04-01. PMID:1665105. |
however, in striatum, dopaminergic innervation does not appear to affect cn levels. |
1992-04-01 |
2023-08-11 |
human |
| J F Chen, B Weis. Ontogenetic expression of D2 dopamine receptor mRNA in rat corpus striatum. Brain research. Developmental brain research. vol 63. issue 1-2. 1992-04-01. PMID:1665109. |
these results suggest that the postnatal development of the d2r mrna in rat striatum correlates well with the ontogeny of the d2 dopamine receptor, that the developmental expression of the d2r mrna is highly associated with the maturation and differentiation of striatal neurons, and that the development of the d2r mrna in rat striatum, unlike that of proenkephalin mrna, can proceed even with reduced dopaminergic afferent input from the substantia nigra. |
1992-04-01 |
2023-08-11 |
rat |
| J A Angul. Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain. Journal of neurochemistry. vol 58. issue 3. 1992-03-13. PMID:1346626. |
the data demonstrate that acute treatment with dopaminergic d2 agonists and antagonists affects proenkephalin mrna abundance in the striatum and accumbens via a d2 receptor mechanism, consistent with the concept that d2 receptor function inhibits the synthesis of the mrna encoding the enkephalin peptides. |
1992-03-13 |
2023-08-11 |
rat |
| H Nissbrandt, G Engberg, E Pilebla. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra. Naunyn-Schmiedeberg's archives of pharmacology. vol 344. issue 1. 1992-03-02. PMID:1663587. |
furthermore, a large part of the da taken up by the dopaminergic terminals in the striatum and in the limbic forebrain seems to be re-incorporated into the storage vesicles. |
1992-03-02 |
2023-08-11 |
rat |
| S J Augood, H Kiyama, R L Faull, P C Emso. Dopaminergic D1 and D2 receptor antagonists decrease prosomatostatin mRNA expression in rat striatum. Neuroscience. vol 44. issue 1. 1992-02-21. PMID:1685231. |
dopaminergic d1 and d2 receptor antagonists decrease prosomatostatin mrna expression in rat striatum. |
1992-02-21 |
2023-08-11 |
rat |